Shanghai Runda Medical Technology Co., Ltd. (SHA:603108)
16.37
-0.29 (-1.74%)
Feb 4, 2026, 2:45 PM CST
SHA:603108 Revenue
Shanghai Runda Medical Technology had revenue of 1.80B CNY in the quarter ending September 30, 2025, a decrease of -11.91%. This brings the company's revenue in the last twelve months to 7.40B, down -12.21% year-over-year. In the year 2024, Shanghai Runda Medical Technology had annual revenue of 8.31B, down -9.13%.
Revenue (ttm)
7.40B
Revenue Growth
-12.21%
P/S Ratio
1.36
Revenue / Employee
2.36M
Employees
3,137
Market Cap
10.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.31B | -835.59M | -9.13% |
| Dec 31, 2023 | 9.15B | -1.35B | -12.84% |
| Dec 31, 2022 | 10.49B | 1.63B | 18.45% |
| Dec 31, 2021 | 8.86B | 1.79B | 25.33% |
| Dec 31, 2020 | 7.07B | 17.21M | 0.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dian Diagnostics Group | 10.50B |
| Guangzhou Kingmed Diagnostics Group | 6.11B |
| BGI Genomics | 3.71B |
| Maccura Biotechnology Co.Ltd | 2.21B |
| Shanghai Labway Clinical Laboratory | 1.52B |
| Beijing Strong Biotechnologies,Inc. | 1.43B |
| Thalys Medical Technology Group | 1.25B |
| Amoy Diagnostics | 1.13B |